{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:13:47Z","timestamp":1789197227736,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"DOI":"10.1007\/s12010-026-05918-0","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:57:30Z","timestamp":1789196250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP2-Mediated Deubiquitination of \u03b2-catenin Drives Colorectal Adenocarcinoma Progression and Immune Evasion"],"prefix":"10.1007","author":[{"given":"Xiaoling","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"5918_CR1","doi-asserted-by":"crossref","unstructured":"Jo, A., & Oh, H. (2019) Incidence of Colon Cancer Related to Cigarette Smoking and Alcohol Consumption in Adults with Metabolic Syndrome: Prospective Cohort Study. Journal of Korean Academy of Nursing\u00a049(6):713\u2013723.","DOI":"10.4040\/jkan.2019.49.6.713"},{"issue":"1","key":"5918_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3393\/ac.2019.03.03","volume":"1","author":"J Lykke","year":"2020","unstructured":"Lykke, J., Roikjaer, O., Jess, P., Rosenberg, J., & On, B. O. T. D. (2020). Identification of Risk Factors Associated With Stage III Disease in Nonmetastatic Colon Cancer: Results From a Prospective National Cohort Study. Annals of Coloproctology, 1(1), 316\u2013322.","journal-title":"Annals of Coloproctology"},{"issue":"1\/1","key":"5918_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/ecco-jcc\/jjaa040","volume":"2020","author":"SC Shah","year":"2020","unstructured":"Shah, S. C., & Itzkowitz, S. H. (2020). Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD. Journal of Crohn\u2019s and colitis, 2020(1\/1), 1172\u20131177.","journal-title":"Journal of Crohn\u2019s and colitis"},{"issue":"1","key":"5918_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21037\/atm.2020.01.52","volume":"2020\/1","author":"Z Li","year":"2020","unstructured":"Li, Z., Liu, X., Kao, X., Chen, Y., Han, S., Huang, M., et al. (2020). Clinicopathological characteristics and prognosis of colorectal mucinous adenocarcinoma and nonmucinous adenocarcinoma: A surveillance, epidemiology, and end results (SEER) population-based study. Annals of Translational Medicine, 2020\/1(1), 205.","journal-title":"Annals of Translational Medicine"},{"key":"5918_CR5","doi-asserted-by":"crossref","unstructured":"Marx, O. M., Mankarious, M. M., Koltun, W. A., & Yochum, G. S. (2024) Identification of differentially expressed genes and splicing events in early-onset colorectal cancer.\u00a0Frontiers in Oncology\u00a01 (20);14:1365762.","DOI":"10.3389\/fonc.2024.1365762"},{"key":"5918_CR6","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, L., Meng, X., Ye, S., & Ma, L. (2022) Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics.\u00a0Frontiers in Cell and Developmental Biology,\u00a01(20);10:897568.","DOI":"10.3389\/fcell.2022.897568"},{"key":"5918_CR7","doi-asserted-by":"crossref","unstructured":"Ren, X., Chen, W., Liu, Y., Chen, Z., Wang, X., & Sun, X. (2025) TRPV4 as a Novel Regulator of Ferroptosis in Colon Adenocarcinoma: Implications for Prognosis and Therapeutic Targeting.\u00a0Digestive Diseases and Sciences, 70(3):1064\u20131077.","DOI":"10.1007\/s10620-025-08843-0"},{"key":"5918_CR8","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Feng, X., Chen, B., Wu, Y., Wang, X., Tang, Z. (2025) CDCA genes as prognostic and therapeutic targets in Colon adenocarcinoma. Hereditas 162(1):19.","DOI":"10.1186\/s41065-025-00368-w"},{"key":"5918_CR9","doi-asserted-by":"crossref","unstructured":"Yang, Q., Zhang, H., Luo, J., Yu, H., Yang, X., & Wang, C. (2025) FADS2 inhibits colorectal cancer cell proliferation by regulating ferroptosis through SLC7A11\/GPX4.\u00a0Molecular Biology Reports\u00a052(1):394.","DOI":"10.1007\/s11033-025-10395-5"},{"key":"5918_CR10","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhou, M., Huang, X., Chen, P., Li, Q., Wang, Y. (2025) A Mechanistic Study of the Feasibility of Ursodeoxycholic Acid in the Treatment of Colon Adenocarcinoma.\u00a0Drug Design, Development and Therapy,\u00a019:1839\u20131852.","DOI":"10.2147\/DDDT.S500721"},{"key":"5918_CR11","doi-asserted-by":"crossref","unstructured":"Li, S., Ye, J., Yang, K., Xu, C., Qin, Z., Xue, Y. (2025) Targeting the AURKB-MAD2L2 Axis Disrupts the DNA Damage Response and Glycolysis to Inhibit Colorectal Cancer Progression. Frontiers in Bioscience-Landmark,\u00a030(2):26532.","DOI":"10.31083\/FBL26532"},{"key":"5918_CR12","doi-asserted-by":"crossref","unstructured":"Chen, S., Zhuang, H., Deng, X., Wu, Y., Chen, M., Wang, C. (2024). USP6 and circCYFIP2 target oncoprotein GOLPH3 for deubiquitination and induce platinum resistance in colon cancer.\u00a0Biochemical Pharmacology 225:116274.","DOI":"10.1016\/j.bcp.2024.116274"},{"key":"5918_CR13","doi-asserted-by":"crossref","unstructured":"Guo, J., Zhao, J., Fu, W., Xu, Q., & Huang, D. (2022) Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.\u00a0Frontiers in Immunology, 13:918314.","DOI":"10.3389\/fimmu.2022.918314"},{"key":"5918_CR14","doi-asserted-by":"crossref","unstructured":"Tian, T., Bi, H., Liu, Y., Li, G., Zhang, Y., Cao, L. (2020). Copy number variation of ubiquitin- specific proteases genes in blood leukocytes and colorectal cancer.\u00a0Cancer Biology & Therapy. [Research Support, Non-U.S. Gov\u2019t] 21(7):637\u2013646.","DOI":"10.1080\/15384047.2020.1750860"},{"issue":"1","key":"5918_CR15","first-page":"13","volume":"2025\/1","author":"Y Gong","year":"2025","unstructured":"Gong, Y., Li, R., Zhang, R., & Jia, L. (2025). USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC. BMC Medical Genomics, 2025\/1(1), 13\u201339.","journal-title":"BMC Medical Genomics"},{"key":"5918_CR16","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Y., Luo, H., Wei, W., Liu, W., Wang, W. (2024) Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.\u00a0Acta Pharmaceutica Sinica B, 14(12):5235\u20135248.","DOI":"10.1016\/j.apsb.2024.08.019"},{"key":"5918_CR17","doi-asserted-by":"crossref","unstructured":"Yang, D., Liu, X., Yang, Y., Long, Y., Nan, D., Shi, B. (2024) Pharmacological USP2 targeting suppresses ovarian cancer growth by potentiating apoptosis and ferroptosis.\u00a0Archives of Biochemistry and Biophysics, 1;762:110193.","DOI":"10.1016\/j.abb.2024.110193"},{"key":"5918_CR18","doi-asserted-by":"crossref","unstructured":"Kuang, Z., Liu, X., Zhang, N., Dong, J., Sun, C., Yin, M. (2023). USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1.\u00a0Cell Death & Differentiation 30(10):2249\u20132264.","DOI":"10.1038\/s41418-023-01219-9"},{"key":"5918_CR19","doi-asserted-by":"crossref","unstructured":"Xu, F., Xu, X., Deng, H., Yu, Z., Huang, J., Deng, L. (2024) The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression. Translational Oncology 1;49:102104.","DOI":"10.1016\/j.tranon.2024.102104"},{"key":"5918_CR20","doi-asserted-by":"crossref","unstructured":"Zhang, J., Liu, S., Li, Q., Shi, Y., Wu, Y., Liu, F. (2020). The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.\u00a0Cell Death & Differentiation. 27(9):2710-25.","DOI":"10.1038\/s41418-020-0538-8"},{"issue":"1","key":"5918_CR21","doi-asserted-by":"publisher","first-page":"9263","DOI":"10.1007\/s00432-023-04855-3","volume":"2023\/1","author":"C Wei","year":"2023","unstructured":"Wei, C., Zhao, X., Zhang, H., & Wang, L. (2023). USP2 promotes cell proliferation and metastasis in choroidal melanoma via stabilizing Snail. Journal of Cancer Research and Clinical, 2023\/1(1), 9263\u20139276.","journal-title":"Journal of Cancer Research and Clinical"},{"key":"5918_CR22","doi-asserted-by":"crossref","unstructured":"Bian, J., Dannappel, M., Wan, C., & Firestein, R. (2020) Transcriptional Regulation of Wnt\/beta-Catenin Pathway in Colorectal Cancer. Cells-Basel 19;9(9).","DOI":"10.3390\/cells9092125"},{"key":"5918_CR23","doi-asserted-by":"crossref","unstructured":"Chen, X., Tu, J., Yang, M., Wang, Y., Liu, B., Qiu, H. (2024) RUNX1-MUC13 Interaction Activates Wnt\/beta-Catenin Signaling Implications for Colorectal Cancer Metastasis.\u00a0International Journal of Biological Sciences 20(12):4999\u20135026.","DOI":"10.7150\/ijbs.98396"},{"issue":"1\/1;20(14","key":"5918_CR24","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.7150\/ijbs.95875","volume":"2024","author":"JM Garc\u00eda-Mart\u00ednez","year":"2024","unstructured":"Garc\u00eda-Mart\u00ednez, J. M., Chocarro-Calvo, A., Mart\u00ednez-Useros, J., Regueira-Acebedo, N., Fern\u00e1ndez-Ace\u00f1ero, M. J., Mu\u00f1oz, A., et al. (2024). SIRT1 Mediates the Antagonism of Wnt\/\u03b2-Catenin Pathway by Vitamin D in Colon Carcinoma Cells. \u00a0International Journal of Biological Sciences, 2024(1\/1;20(14), 5495\u20135509.","journal-title":"International Journal of Biological Sciences"},{"issue":"1;75(1","key":"5918_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jpp\/rgac067","volume":"2023\/1","author":"S Li","year":"2023","unstructured":"Li, S., Shi, C., Fu, W., & Zhang, J. (2023). Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt\/\u03b2-catenin regulatory axis in colorectal cancer. Journal of Pharmacy and Pharmacology, 2023\/1(1;75(1), 129\u2013138.","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1\/1","key":"5918_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/molecules25030703","volume":"2020","author":"H Li","year":"2020","unstructured":"Li, H., Jeong, J. H., Kwon, S. W., Lee, S. K., Lee, H. J., & Ryu, J. (2020). Z-Ajoene Inhibits Growth of Colon Cancer by Promotion of CK1\u03b1 Dependent \u03b2-Catenin Phosphorylation. Molecules (Basel Switzerland), 2020(1\/1), 703.","journal-title":"Molecules (Basel Switzerland)"},{"key":"5918_CR27","doi-asserted-by":"crossref","unstructured":"Wang, S., Ma, K., Zhou, C., Wang, Y., Hu, G., Chen, L. (2019) LKB1 and YAP phosphorylation play important roles in Celastrol-induced beta-catenin degradation in colorectal cancer.\u00a0Therapeutic Advances in Medical Oncology, 1(20);11:432508520.","DOI":"10.1177\/1758835919843736"},{"key":"5918_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.68","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Wang, Z., Liu, K., Liu, Y., Wang, S., Jiang, W., et al. (2024). Targets of tumor microenvironment for potential drug development. MedComm \u2013 Oncology, 3 (1). https:\/\/doi.org\/10.1002\/mog2.68","journal-title":"MedComm \u2013 Oncology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05918-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:57:38Z","timestamp":1789196258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05918-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":28,"alternative-id":["5918"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05918-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"24 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical study was approved by the Ethics Committee of Hangzhou TCM Hospital affiliated to Zhejiang Chinese Medical University. Informed consent was obtained from all individual participants included in the study. This study was performed in line with the principles of the Declaration of Helsinki. The animal study was approved by the Ethics Committee of Hangzhou TCM Hospital affiliated to Zhejiang Chinese Medical University. All animal experiments complied with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}